Organic & Biomolecular Chemistry
Paper
Then it was filtrated and washed with EtOAc. The filtrate was
quenched with water and saturated NaHCO3 solution was
added until pH 10. It was extracted with EtOAc three times, the
combined organic layers were dried over anhydrous Na2SO4
and evaporated under reduced pressure. The residue was puri-
fied by column chromatography (silica gel, heptanes/EtOAc =
3/1) and gave 20 as a light brown oil (0.578 mmol, 137 mg,
G. Haumont, C. Jarry and D. Mossalayi, Bioorg. Med. Chem.,
2007, 15, 194–210.
5 (a) F. Zhang, Y. Xi, Y. Lu, L. Wang, L. Liu, J. Li and Y. Zhao,
Chem. Commun., 2014, 50, 5771–5773; (b) H. A. Oskooie,
M. M. Heravi, K. Bakhtiari and S. Taheri, Monatsh. Chem.
Chem. Mon., 2007, 138, 875–877; (c) N. Xekoukoulotakis,
C. Hadjiantoniou-Maroulis and A. Maroulis, Tetrahedron
Lett., 2000, 41, 10299–10302; (d) C. Qi, H. Jiang, L. Huang,
Z. Chen and H. Chen, Synthesis, 2011, 387–396;
(e) P. Ghosh and A. Mandal, Green Chem. Lett. Rev., 2012, 5,
127–134.
6 (a) F. Buron, A. Turck, N. Plé, L. Bischoff and F. Marsais,
Tetrahedron Lett., 2007, 48, 4327–4330; (b) G. Liu, G. Xu,
J. Li, D. Ding and J. Sun, Org. Biomol. Chem., 2014, 12,
1387–1390; (c) Z. Chen, D. Ye, G. Xu, M. Ye and L. Liu, Org.
Biomol. Chem., 2013, 11, 6699–6702.
7 (a) C. Venkatesh, B. Singh, P. K. Mahata, H. Ila and
H. Junjappa, Org. Lett., 2005, 7, 2169–2172; (b) Z.-J. Yang,
C.-Z. Liu, B.-L. Hu, C.-L. Deng and X.-G. Zhang, Chem.
Commun., 2014, 50, 14554–14557.
8 (a) F. Chen, X. Huang, X. Li, T. Shen, M. Zou and N. Jiao,
Angew. Chem., Int. Ed., 2014, 126, 10663–10667;
(b) K. K. D. Rao Viswanadham, M. Prathap Reddy,
P. Sathyanarayana, O. Ravi, R. Kant and S. R. Bathula,
Chem. Commun., 2014, 50, 13517–13520.
1
85%). H NMR (300 MHz, CDCl3, 298 K): δ = 2.34 (s, 3H), 3.49
(br s, 3H), 4.14 (s, 2H), 6.73–6.89 (m, 4H), 7.10 (d, J = 8.0 Hz,
2H), 7.31 (d, J = 8.0 Hz, 2H) ppm; 13C NMR (75 MHz, CDCl3,
298 K): δ = 21.6, 35.1, 83.8, 85.9, 113.4, 116.6, 120.0, 120.1,
120.6, 129.1 (2C), 131.7 (2C), 135.3, 136.6, 138.4 ppm;
IR (film): ν = 3334, 2920, 1597, 1508, 1450, 1271, 816,
¯
740 cm−1; HRMS (ESI): m/z calcd for C16H16N2: 237.1386
[M + H]+; found: 237.1384.
4-(p-Tolyl)quinolin-8-amine (21). Pale yellow oil; 1H NMR
(700 MHz, CDCl3, 298 K): δ = 2.46 (s, 3H), 5.05 (br s, 2H), 6.94
(dd, J = 1.9 Hz, 6.7 Hz, 1H), 7.24–7.30 (m, 3H), 7.32 (d, J =
7.9 Hz, 2H), 7.41 (d, J = 7.9 Hz, 2H), 8.77 (d, J = 4.4 Hz, 1H)
ppm; 13C NMR (176 MHz, CDCl3, 298 K): δ = 21.3, 109.9, 114.3,
121.7, 127.2, 127.4, 129.1 (2C), 129.4 (2C), 135.7, 138.1, 138.8,
144.2, 146.9, 148.4 ppm; IR (film): ν = 3447, 3319, 2360, 1618,
¯
1502, 1358, 1282, 818, 761 cm−1; HRMS (ESI): m/z calcd for
C16H14N2: 235.1230 [M + H]+; found: 235.1230.
9 (a) D. D. Vachhani, V. P. Mehta, S. G. Modha, K. van Hecke,
L. VanMeervelt and E. V. Van der Eycken, Adv. Synth. Catal.,
2012, 354, 1593–1599; (b) Q. Yang, T. Xu and Z. Yu, Org.
Lett., 2014, 16, 6310–6313; (c) D. D. Vachhani, S. G. Modha,
A. Sharma and E. V. Van der Eycken, Tetrahedron, 2013, 69,
359–365; (d) S. Jalal, K. Bera, S. Sarkar, K. Paul and U. Jana,
Org. Biomol. Chem., 2014, 12, 1759–1770.
Acknowledgements
WS kindly acknowledges the financial support of the project
836532 (“Prä-klinische Entwicklung einer Off-the-Shelf indvi-
dualisierten Krebsimmuntherapie”) by the Austrian Research
Promotion Agency (FFG). The NMR spectrometers were
acquired in collaboration with the University of South 10 (a) B. M. Monks, E. R. Fruchey and S. P. Cook, Angew.
Bohemia (CZ) with financial support from the European
Union through the EFRE INTERREG IV ETC-AT-CZ program
(project M00146, “RERI-uasb”).
Chem., Int. Ed., 2014, 53, 11065–11069; (b) V. G. Zaitsev,
D. Shabashov and O. Daugulis, J. Am. Chem. Soc., 2005,
127, 13154–13155.
11 C. E. Meyet and C. H. Larsen, J. Org. Chem., 2014, 79, 9835–
9841.
12 A. Shi, T. A. Nguyen, S. K. Battina, S. Rana, D. J. Takemoto,
P. K. Chiang and D. H. Hua, Bioorg. Med. Chem. Lett., 2008,
18, 3364–3368.
13 (a) M. Rehan, G. Hazra and P. Ghorai, Org. Lett., 2015, 17,
1668–1671; (b) X. Zhang, M. A. Campo, T. Yao and
R. C. Larock, Org. Lett., 2005, 7, 763–766; (c) G. A. Salman,
R. U. Nisa, V. O. Iaroshenko, J. Iqbal, K. Ayub and
P. Langer, Org. Biomol. Chem., 2012, 10, 9464–9473.
Notes and references
1 (a) I. J. Krems and P. E. Spoerri, Chem. Rev., 1947, 40, 279–
358; (b) W. Kaim, Angew. Chem., 1983, 95, 201–221.
2 (a) R. Müller and S. Rappert, Appl. Microbiol. Biotechnol.,
2010, 85, 1315–1320; (b) P. Sjödin, H. Wallin, J. Alexander
and M. Jägerstad, Carcinogenesis, 1989, 10, 1269–1275.
3 (a) V. P. Mehta, A. Sharma, K. van Hecke, L. van Meervelt
and E. V. Van der Eycken, J. Org. Chem., 2008, 73, 2382– 14 (a) G. S. Welmaker, J. A. Nelson, J. E. Sabalski, A. L. Sabb,
2388; (b) S. G. Modha, J. C. Trivedi, V. P. Mehta,
D. S. Ermolat’ev and E. V. Van der Eycken, J. Org. Chem.,
2011, 76, 846–856; (c) A. Zaid, J.-S. Sun, C.-H. Nguyen,
E. Bisagni, T. Garestier, D. S. Grierson and R. Zain, Chem-
BioChem, 2004, 5, 1550–1557.
J. R. Potoski, D. Graziano, M. Kagan, J. Coupet, J. Dunlop,
H. Mazandarani, S. Rosenzweig-Lipson, S. Sukoff and
Y. Zhang, Bioorg. Med. Chem. Lett., 2000, 10, 1991–1994;
(b) M. de F. Pereira and V. Thiéry, Org. Lett., 2012, 14, 4754–
4757.
4 (a) S. B. Ferreira and C. R. Kaiser, Expert Opin. Ther. 15 (a) N. Rajesh, R. Sarma and D. Prajapati, Synlett, 2014,
Patents, 2012, 22, 1033–1051; (b) J. Guillon, I. Forfar,
M. Mamani-Matsuda, V. Desplat, M. Saliège, D. Thiolat,
S. Massip, A. Tabourier, J.-M. Léger, B. Dufaure,
1448–1452; (b) K. Surendra, W. Qiu and E. J. Corey, J. Am.
Chem. Soc., 2011, 133, 9724–9726; (c) Y. Zhang, P. Li,
M. Wang and L. Wang, J. Org. Chem., 2009, 74, 4364–4367.
This journal is © The Royal Society of Chemistry 2015
Org. Biomol. Chem.